FDA grants full approval to Alzheimer's drug Leqembi, triggering expanded Medicare coverage for patients
FDA approves Alzheimer's drug, Leqembi, making it the first effective drug in reducing the symptoms of this brain disease.
Alzheimer’s
The Voice of Miami’s Hispanic Community—Your Miami Culture Pulse Connecting Business, Culture, and Leadership.
Trusted local journalism. Real community impact. Stories that matter.